Responses
Treatments
Original research
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure
Compose a Response to This Article
Other responses
No responses have been published for this article.